FDA Adverse Event Malfunction Summary report: N

DCA VANTAGE

MDR report key: 22368544 · Received July 1, 2025

Report

Report Number
3002637618-2025-00051
Event Type
Malfunction
Date Received
July 1, 2025
Date of Event
November 4, 2024
Report Date
September 4, 2025
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
CGX
UDI-DI
00630414551364
PMA / PMN Number
K071466
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE CUSTOMER HAS STATED THAT THEY WERE PERFORMING PROPER MAINTENANCE AND PASSING QUALITY CONTROLS. THE CUSTOMER COMMUNICATED THAT THEY DID NOT HAVE ANY REMAINING REAGENT AVAILABLE. WITHOUT THE RETURNED REAGENT, AN INVESTIGATION CANNOT PROCEED AND THEREFORE THE ROOT CAUSE CANNOT BE DETERMINED. THE DCU REVIEWED THE CERTIFICATE OF ANALYSIS FOR LOT IN USE AT THE TIME OF THE EVENT, AND THE PRODUCT MET AND PASSED ALL SPECIFICATIONS UPON MANUFACTURING RELEASE. THE CAUSE OF THIS EVENT IN UNKNOWN. NO PRODUCT PROBLEM IDENTIFIED.

Additional Manufacturer Narrative · 0

THE AFFECTED TEST DUE TO THE DEVICE MALFUNCTION IS CREATININE. HENCE THE PRODUCT CODE IS CHANGED TO CGX IN THE SECTION D2A.

Description of Event or Problem · 0

THE CUSTOMER REPORTED THAT THEY RECEIVED DISCREPANT MICROALBUMIN, CREATININE AND ALBUMIN-CREATININE RATIO RESULT ON THEIR DCA VANTAGE INSTRUMENT COMPARED TO LAB TEST. THE PATIENT'S RESULTS WERE CONFIRMED FROM THE LAB TEST. THERE IS NO REPORTED INJURY DUE TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1381910 DCA VANTAGE DCA VANTAGE CGX SIEMENS HEALTHCARE DIAGNOSTICS INC. 00630414551364

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown